Behavioral Treatment of Obsessive-Compulsive Disorders: Current Status

1982 ◽  
Vol 50 (3_suppl) ◽  
pp. 1035-1044 ◽  
Author(s):  
Alan E. Brooker

Behavioral treatment of obsessive-compulsive disorders ranks among the most widely used and widely studied approaches to these problems. Next to sociopathy these disorders have traditionally been regarded as constituting one of the most difficult classes of psychological problems to treat; certainly they present an exceptionally low rate of success. By contrast with the usual insight psychotherapy, behavior therapy usually focuses on the symptoms alone, with little attention to any underlying intrapsychic or environmental conditions that presumably maintain the symptom. Behavior therapy ignores, in short, the total personality or lifestyle. This symptom specificity of treatment has rendered behavioral approaches subject to criticism from practitioners of more traditional approaches. In more recent years, newer techniques and strategies of behavior therapy have rendered some of those criticisms obsolete. A trend toward consideration of other symptoms and the individual's environment has also been noted.

2000 ◽  
Vol 30 (1) ◽  
pp. 27-39 ◽  
Author(s):  
Helmut Peter ◽  
Susanne Tabrizian ◽  
Iver Hand

Objective: Patients with panic disorder are reported to have elevated cholesterol levels. There is also some evidence that cholesterol elevation is not so much a specific condition in panic disorder but is generally associated with anxiety. So far, there is little data on cholesterol levels in patients with obsessive compulsive disorders (OCD) which is also classified as anxiety disorder. Method: Thirty-three patients with OCD participated in the study. Serum cholesterol was measured as pretreatment and at the end of a ten-week treatment-period. All patients received behavior therapy and, in a double-blind fashion, fluvoxamine or placebo. Severity of OCD was assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Results: Pretreatment cholesterol values of OCD patients were compared with cholesterol levels of thirty panic disorder patients and thirty normal controls. OCD patients had elevated cholesterol levels comparable with those of panic disorder patients. Cholesterol levels decreased significantly from pre- to posttreatment. OCD patients with high cholesterol levels (≥ 240 mg/dl, n = 7) could make best use of the treatment whereas patients with desirable cholesterol levels (< 200 mg/dl, n = 11) did not change their cholesterol during treatment. Conclusions: Our data support the assumption that not only panic disorder but also other anxiety disorders, e.g., obsessive compulsive disorders, may be associated with serum cholesterol elevations. Effective treatment (behavior therapy and/or treatment with a selective serotonin reuptake inhibitor [SSRI]) seems to decrease cholesterol levels, especially in patients with pathological cholesterol elevations.


PLoS ONE ◽  
2017 ◽  
Vol 12 (3) ◽  
pp. e0173660 ◽  
Author(s):  
Paul-Christian Bürkner ◽  
Nadine Bittner ◽  
Heinz Holling ◽  
Ulrike Buhlmann

Sign in / Sign up

Export Citation Format

Share Document